Status:
COMPLETED
Effect of Helicobacter Pylori Treatment on Idiopathic Central Serous Chorioretinopathy (ICSCR)
Lead Sponsor:
Tabriz University
Conditions:
Central Serous Chorioretinopathy
Eligibility:
All Genders
28-40 years
Phase:
PHASE1
PHASE2
Brief Summary
Etiology of ICSCR is not known however recent studies regard the role of immunologic and infectious processes in the pathogenesis of ICSCR.one of these hypothesis is the role of helicobacter pylori in...
Detailed Description
we will choose 50 cases of patients with ICSCR who are infected with h.pylori.25 cases will receive anti h.pylori regiment and 25 cases as controls will receive no medication.then we will compare the ...
Eligibility Criteria
Inclusion
- the persons who are infected with helicobacter pylori and have ICSCR
Exclusion
- history of previous eye surgery ,to have indication of laser therapy,corticosteroid therapy,pregnancy,
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2009
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00817245
Start Date
March 1 2008
End Date
January 1 2009
Last Update
January 6 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alireza JavadzadehTabriz
Tabriz, Iran